Lineage Cell (LCTX) Launches Its Latest Cell Therapy Program [Yahoo! Finance]
Lineage Cell Therapeutics, Inc. (LCTX)
Company Research
Source: Yahoo! Finance
On March 24, Lineage Cell Therapeutics Inc. (NYSE:LCTX) announced the launch of COR1, a new preclinical cell therapy program targeting corneal endothelial disease. The company is leveraging its proprietary AlloSCOPE platform to develop scalable off-the-shelf cell therapies aimed at addressing the global shortage of donor corneal cells. Management highlighted the program as a natural extension of its platform and a step toward expanding its presence in ophthalmology while supporting long-term growth. Commenting on the update, CEO Brian Culley stated: “We have elected to advance the COR1 program into preclinical testing and we also believe the recent accomplishments reported with our AlloSCOPE “5D” manufacturing process could be applied to this program to further reduce production costs through large-scale production.” Billion Photos/Shutterstock.com Earlier on March 6, Lineage Cell Therapeutics Inc. (NYSE:LCTX) reported fourth quarter revenue of $6.6 million compared to $2.9 mil
Show less
Read more
Impact Snapshot
Event Time:
LCTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LCTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LCTX alerts
High impacting Lineage Cell Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LCTX
News
- Lineage Launches New Cell Therapy Program in Corneal Endothelial DiseaseBusiness Wire
- Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateBusiness Wire
- Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 [Yahoo! Finance]Yahoo! Finance
- Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026Business Wire